Search This Blog

Thursday, December 19, 2019

FDA OKs Bausch Health’s acne lotion Arazlo

The FDA approves Bausch Health Companies (NYSE:BHC) unit Ortho Dermatologics’ Arazlo (tazarotene) Lotion, 0.045% for the topical treatment of acne vulgaris in patients at least nine years old.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)